Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Endotoxin Testing in Aseptic Aerosols

Posted on By

SOP for Endotoxin Testing in Aseptic Aerosols

Standard Operating Procedure for Endotoxin Testing in Aseptic Aerosols

1) Purpose

The purpose of this SOP is to establish procedures for conducting endotoxin testing on aseptic aerosol products to ensure the absence of endotoxins, which are critical for product safety.

2) Scope

This SOP applies to endotoxin testing performed on aseptic aerosol products manufactured by [Company Name] to ensure compliance with regulatory standards and product safety.

3) Responsibilities

Microbiology Laboratory: Perform endotoxin testing according to approved protocols and regulatory guidelines.
Quality Control (QC) Team: Provide aerosol samples for testing and coordinate sample collection.
Regulatory Affairs: Review and approve endotoxin testing protocols to ensure compliance with regulatory guidelines.
Quality Assurance (QA) Team: Oversee adherence to SOPs and ensure documentation accuracy and completeness.

4) Procedure

4.1 Sample Collection and Preparation:
4.1.1 Collect representative samples of aseptic aerosol products from the final production batch under aseptic conditions.
4.1.2 Ensure samples are properly labeled and identified to maintain traceability.
4.1.3 Store samples under appropriate conditions (e.g., refrigerated) prior to testing to preserve sample integrity.

See also  SOP for Root Cause Analysis in Aerosol Production

4.2 Test Setup and Reagents Preparation:
4.2.1 Prepare reagents and solutions required for endotoxin testing, following compendial guidelines (e.g., Limulus Amebocyte Lysate – LAL reagent).
4.2.2 Ensure all reagents and solutions are sterile

and free from endotoxins.
4.2.3 Calibrate the LAL testing system or equipment according to the manufacturer’s instructions.

4.3 Endotoxin Testing Procedure:
4.3.1 Inoculate sample wells with prepared aerosol samples, ensuring accurate volume and proper dispersion.
4.3.2 Add LAL reagent to each well, following the manufacturer’s protocol, and mix thoroughly.
4.3.3 Incubate the sample wells at the specified temperature (e.g., 37°C) for the required duration (e.g., 60 minutes) to allow endotoxin reaction.

4.4 Detection and Reading:
4.4.1 Observe the sample wells for color change or turbidity, indicating the presence of endotoxins.
4.4.2 Use a photometer or LAL reader to quantify endotoxin levels in the samples, following the instrument’s calibration and procedure.
4.4.3 Record and document all test results, including absorbance values and endotoxin concentration.

See also  SOP for Analytical Method Development for Aerosols

4.5 Controls and Validation:
4.5.1 Include appropriate positive and negative controls in each endotoxin test to validate test procedures and reagents.
4.5.2 Ensure controls meet acceptance criteria before interpreting sample results.
4.5.3 Perform validation of endotoxin testing methods and procedures according to regulatory requirements.

4.6 Result Interpretation:
4.6.1 Evaluate test results after the specified incubation period to determine the presence or absence of endotoxins.
4.6.2 Compare test results against predefined acceptance criteria for endotoxin levels.
4.6.3 Document all test results, including raw data, observations, and interpretations.

4.7 Reporting and Documentation:
4.7.1 Prepare detailed endotoxin test reports summarizing testing methods, results, and conclusions.
4.7.2 Review and approve test reports by designated personnel to ensure accuracy and compliance with SOPs.
4.7.3 Maintain records of all endotoxin testing activities, including sample preparation, reagent preparation, testing, and approval documentation.

See also  SOP for HVAC System Maintenance in Aerosol Production

4.8 Non-Conformance Handling:
4.8.1 Initiate non-conformance reports (NCRs) for aseptic aerosol products that fail endotoxin testing or exceed acceptance criteria.
4.8.2 Investigate root causes of non-conformance and implement corrective actions to prevent recurrence.
4.8.3 Verify effectiveness of corrective actions through retesting and document outcomes accordingly.

5) Abbreviations, if any

SOP: Standard Operating Procedure
QC: Quality Control
QA: Quality Assurance
NCR: Non-Conformance Report
LAL: Limulus Amebocyte Lysate

6) Documents, if any

Endotoxin Testing Protocol
Endotoxin Test Reports
Reagent Preparation Records
Calibration Records for LAL Testing Equipment
Validation Reports for Endotoxin Testing Methods
Non-Conformance Reports (NCRs)
Approval Records and Documentation

7) Reference, if any

USP Chapter Endotoxin Testing – General Information
EP Chapter Endotoxin Testing – Microbial Enumeration Tests
ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

8) SOP Version

Version 1.0

Aerosols Tags:Aerosol batch manufacturing, Aerosol change control procedures, Aerosol cleaning validation, Aerosol contamination prevention, Aerosol documentation requirements, Aerosol equipment calibration, Aerosol equipment cleaning, Aerosol final product inspection, Aerosol formulation development, Aerosol in-process testing, Aerosol manufacturing process, Aerosol method development, Aerosol microbial testing, Aerosol packaging guidelines, Aerosol particle size analysis, Aerosol personnel training, Aerosol process validation, Aerosol production SOP, Aerosol quality control, Aerosol raw material inspection, Aerosol stability testing, Aerosol stability testing methods, Aerosol sterility maintenance, Aerosol storage conditions, Aerosol waste disposal procedures

Post navigation

Previous Post: SOP for Documentation in Transdermal Patches Production
Next Post: SOP for Training Personnel in Transdermal Patches Production

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version